Back to Journals » Lung Cancer: Targets and Therapy » Volume 15
Commentary
MARIPOSA: Can Amivantamab and Lazertinib Replace Osimertinib in the Front-Line Setting?
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
1,012 | Dovepress* | 1,012+ | 18 | 1,030 | |
Totals | 1,012 | 18 | 1,030 | ||
*Since 12 April 2024 |
View citations on PubMed Central and Google Scholar